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Abstract: p53-binding protein 1 (53BP1) regulates both the DNA damage response and p53 signaling.
Although 53BP1’s function is well established in DNA double-strand break repair, how its role in p53
signaling is modulated remains poorly understood. Here, we identify the scaffolding protein AHNAK as a
G1 phase-enriched interactor of 53BP1. We demonstrate that AHNAK binds to the 53BP1 oligomeriza-
tion domain and controls its multimerization potential. Loss of AHNAK results in hyper-accumulation of
53BP1 on chromatin and enhanced phase separation, culminating in an elevated p53 response, compromis-
ing cell survival in cancer cells but leading to senescence in non-transformed cells. Cancer transcriptome
analyses indicate that AHNAK-53BP1 cooperation contributes to the suppression of p53 target gene
networks in tumors and that loss of AHNAK sensitizes cells to combinatorial cancer treatments. These
findings highlight AHNAK as a rheostat of 53BP1 function, which surveys cell proliferation by preventing
an excessive p53 response.
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SUMMARY
p53-binding protein 1 (53BP1) regulates both the DNA damage response and p53 signaling. Although
53BP1’s function is well established in DNA double-strand break repair, how its role in p53 signaling is modu-
lated remains poorly understood. Here, we identify the scaffolding protein AHNAK as a G1 phase-enriched
interactor of 53BP1. We demonstrate that AHNAK binds to the 53BP1 oligomerization domain and controls
its multimerization potential. Loss of AHNAK results in hyper-accumulation of 53BP1 on chromatin and
enhanced phase separation, culminating in an elevated p53 response, compromising cell survival in cancer
cells but leading to senescence in non-transformed cells. Cancer transcriptome analyses indicate that AH-
NAK-53BP1 cooperation contributes to the suppression of p53 target gene networks in tumors and that
loss of AHNAK sensitizes cells to combinatorial cancer treatments. These findings highlight AHNAK as a
rheostat of 53BP1 function, which surveys cell proliferation by preventing an excessive p53 response.
INTRODUCTION
The tumor suppressor protein p53 plays a pivotal role in trig-
gering multiple signaling pathways in response to a wide range
of cellular stresses. Mechanistically, upon sensing stress, p53
rewires pan-genomic transcriptional programs, which includes
the induction of cell-cycle arrest (e.g., CDKN1A/p21, 14-3-3s),
pro-apoptotic (e.g., BAX, TP53I3, PUMA,), and senescence
(e.g., FAS, PDID) genes. In response to DNA damage, p53 acti-
vation is triggered by the ATM/ATR kinases, the apical
responders to DNA double-stranded breaks (DSBs), and
replication stress, respectively. ATM/ATR-mediated phosphor-
ylation of p53 and of its inhibitor MDM2 initiate a converging
mechanism, leading to the stabilization of p53 (Meek, 2004).
The primary target of activated p53 is a multifunctional protein,
p21, which attenuates cyclin/CDK activity and instigates G1/S
cell-cycle arrest. p21 is also known to activate genes involved
in senescence (Meek, 2004; Mirzayans et al., 2012). In a p53-
deficient background, cells have an impaired G1/S checkpoint,
resulting in the propagation of structural aneuploidies and early
onset of carcinogenesis (Soto et al., 2017). Other studies
(Abbas and Dutta, 2009) have shown that the strength of the
p53 response dictates the balance between cell division and
cell-cycle arrest.
p53-binding protein 1 (53BP1) was identified as an interactor
of p53 (Iwabuchi et al., 1994) and is positioned at the cross-
roads of DSB repair and p53 signaling. It harbors key structural
elements, including 28 N-terminal Ser/Thr-Gln (S/T-Q) sites, a
central minimal focus-forming region (MFFR) composed of an
oligomerization domain (OD), a Gly- and Arg-rich (GAR) motif,
a tandem Tudor domain, a ubiquitylation-dependent recruit-
ment (UDR) motif, and a C-terminal BRCT domain. Whereas
both the OD and BRCT domains are critical for p53 activation,
the BRCT domain is dispensable for DNA repair (Mirman and
de Lange, 2020). 53BP1 is stabilized on chromatin by UDR
motif-mediated binding to H2AUb15, and via binding of its tan-
dem Tudor domain to mono- and dimethylated H4K20 (Panier
and Boulton, 2014). Domains flanking the Tudor domain (i.e.,
OD and the LC8 domain) drive multimerization of 53BP1 and
promote DNA damage-dependent 53BP1 recruitment to the
chromatin (Becker et al., 2018; Sundaravinayagam et al.,
2019; Ward et al., 2006; Zgheib et al., 2009).
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